Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Fig. 2

Associations between levels of complement protein C3 and/or C4 and levels of a, b anti-dsDNA and c, d anti-ribosomal P antigen antibodies in a, c sera obtained with conventional measurement and b, d in corresponding solubilized IC. e Levels of C1q-binding IC in 54/55 of the investigated patients, compared to a population-based non-SLE control group. Horizontal lines indicate median levels, with the corresponding figures shown below each group. ns not significant

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us